semaglutide future The Role of in the Medspa Industry: The of Weight Loss Unveiling the Therapeutic Potential of

Beyond blood sugar control, GLP-1 has a pronounced satiety effect, slows down gastric emptying, and actually reduces postprandial insulin response

Tirzepatides indirect impact on cardiovascular system Glucose and lipid metabolism The study conducted by Karagiannis et al

Glucagon-like peptide-1 (GLP-1) agonists, originally developed to manage type 2 diabetes, are now used to treat obesity due to their metabolic effects (6)

Some of the GLP-1s in the study have not yet been approved specifically for obesity treatment

Effects of GLP-1 Agonists and SGLT2 Inhibitors during Pregnancy and Lactation on Offspring Outcomes: A Systematic Review of the Evidence. Frontiers in Endocrinology, vol